Organization
Sacramento, CA
7 abstracts
Abstract
Analysis of patient-physician portal secure message content and the associated cost savings in oncology practice.Org: San Francisco Medical Center, San Francisco, CA, Kaiser Permanente Northern California, San Rafael Medical Center, The Permanente Medical Group Consulting Services,
Abstract
Safety and clinical activity of target-preserving anti-CTLA-4 antibody ONC-392 as monotherapy in NSCLC patients who progressed on PD(L)1-targeted immunotherapy.Org: James Thoracic Oncology Center, The Ohio State University Comprehensive Cancer Center and Pelotonia Institute for Immuno-Oncology, Columbus, OH, Columbus, OH, Sarah Cannon Research Institute/Tennessee Oncology, Tennessee Oncology, PLLC,
Abstract
A phase 1/2 study of combination olaparib and radium-223 in men with metastatic castration-resistant prostate cancer with bone metastases (COMRADE): A trial in progress.Org: Mount Auburn Hospital, Harvard Medical School, Cambridge, MA, Department of Data Sciences, Dana-Farber Cancer Institute,
Abstract
A phase 1a/1b study of aurora kinase A inhibitor VIC-1911 as monotherapy and in combination with sotorasib for the treatment of KRAS G12C-mutant non–small-cell lung cancer.Org: Yale Cancer Center, Yale School of Medicine, New Haven, CT, Yale School of Medicine, New Haven, CT, NYU Langone-Laura and Isaac Perlmutter Cancer Center, New York, NY,
Abstract
Tissue and plasma-based mechanisms of resistance to first-line osimertinib in EGFR-mutant NSCLC: A multi-institutional cohort.Org: Massachusetts General Hospital, Harvard Medical School, Boston, MA, Columbia University Irving Medical Center, New York, NY, USA, New York, NY,
Abstract
Olutasidenib in post-venetoclax patients with mIDH1 AML.Org: Georgia Cancer Center, Augusta University, Medical College of Georgia at Augusta University, Augusta, GA, Department of Microbiology, Immunology and Molecular Genetics, David Geffen School of Medicine at UCLA,
Abstract
Novel blood-based assay for detection of early stage multi-cancer.Org: University of California, Davis, Sacramento, CA, Dana-Farber Cancer Institute, Boston, MA, Harbinger Health,